Literature DB >> 28933782

Cardiovascular disease in the Eastern Mediterranean region: epidemiology and risk factor burden.

Karam Turk-Adawi1, Nizal Sarrafzadegan2,3, Ibtihal Fadhil4, Kathryn Taubert5, Masoumeh Sadeghi6, Nanette K Wenger7, Nigel S Tan8, Sherry L Grace8,9.   

Abstract

The Eastern Mediterranean region (EMR) comprises 22 countries or territories spanning from Morocco in the west to Pakistan in the east, and contains a population of almost 600 million people. Like many other developing regions, the burden of disease in the EMR has shifted in the past 30 years from primarily communicable diseases to noncommunicable diseases such as cardiovascular disease (CVD). Cardiovascular mortality in the EMR, mostly attributable to ischaemic heart disease, is expected to increase more dramatically in the next decade than in any other region except Africa. The most prominent CVD risk factors in this region include tobacco consumption, physical inactivity, depression, obesity, hypertension, and diabetes mellitus. Many individuals living in the EMR are unaware of their risk factor status, and even if treated, these risk factors are often poorly controlled. Furthermore, infrequent use of emergency medical services, delays in access to care, and lack of access to cardiac catheterization affects the timely diagnosis of CVD. Treatment of CVD is also suboptimal in this region, consisting primarily of thrombolysis, with insufficient provision of timely revascularization. In this Review, we summarize what is known about CVD burden, risk factors, and treatment strategies for individuals living in the EMR. This information will hopefully aid decision-makers when devising strategies on how to improve CVD prevention and management in this region.

Entities:  

Mesh:

Year:  2017        PMID: 28933782     DOI: 10.1038/nrcardio.2017.138

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN: 1759-5002            Impact factor:   32.419


  93 in total

1.  Canadian-American differences in the management of acute coronary syndromes in the GUSTO IIb trial: one-year follow-up of patients without ST-segment elevation. Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) II Investigators.

Authors:  Y Fu; W C Chang; D Mark; R M Califf; B Mackenzie; C B Granger; E J Topol; M Hlatky; P W Armstrong
Journal:  Circulation       Date:  2000-09-19       Impact factor: 29.690

2.  Untangling the relationship between medication adherence and post-myocardial infarction outcomes: medication adherence and clinical outcomes.

Authors:  Niteesh K Choudhry; Robert J Glynn; Jerry Avorn; Joy L Lee; Troyen A Brennan; Lonny Reisman; Michele Toscano; Raisa Levin; Olga S Matlin; Elliott M Antman; William H Shrank
Journal:  Am Heart J       Date:  2013-10-17       Impact factor: 4.749

3.  EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population.

Authors:  Markku S Nieminen; Dirk Brutsaert; Kenneth Dickstein; Helmut Drexler; Ferenc Follath; Veli-Pekka Harjola; Matthias Hochadel; Michel Komajda; Johan Lassus; Jose Luis Lopez-Sendon; Piotr Ponikowski; Luigi Tavazzi
Journal:  Eur Heart J       Date:  2006-09-25       Impact factor: 29.983

4.  Factors affecting outpatient cardiac rehabilitation attendance after acute myocardial infarction and coronary revascularization--a local experience.

Authors:  Muhammad Ali; Faisal Qadir; Salman Javed; Zohaib Nawaz Khan; Sidra Asad; Bashir Hanif
Journal:  J Pak Med Assoc       Date:  2012-04       Impact factor: 0.781

Review 5.  Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials.

Authors:  Ellen C Keeley; Judith A Boura; Cindy L Grines
Journal:  Lancet       Date:  2003-01-04       Impact factor: 79.321

6.  Trends in reperfusion strategies, door-to-needle and door-to-balloon times, and in-hospital mortality among patients with ST-segment elevation myocardial infarction enrolled in the National Registry of Myocardial Infarction from 1990 to 2006.

Authors:  C Michael Gibson; Yuri B Pride; Paul D Frederick; Charles V Pollack; John G Canto; Alan J Tiefenbrunn; W Douglas Weaver; Costas T Lambrew; William J French; Eric D Peterson; William J Rogers
Journal:  Am Heart J       Date:  2008-11-01       Impact factor: 4.749

Review 7.  A systematic review of economic evaluations of cardiac rehabilitation.

Authors:  Wai Pong Wong; Jun Feng; Keng Ho Pwee; Jeremy Lim
Journal:  BMC Health Serv Res       Date:  2012-08-08       Impact factor: 2.655

8.  Atherosclerotic disease and risk factor modification in Saudi Arabia: a call to action.

Authors:  Mohammed Al-Omran
Journal:  Vasc Health Risk Manag       Date:  2012-05-28

Review 9.  The state of heart disease in Sudan.

Authors:  A Suliman
Journal:  Cardiovasc J Afr       Date:  2011 Jul-Aug       Impact factor: 1.167

10.  Prevalence and correlates of coronary heart disease: first population-based study in Lebanon.

Authors:  Rouba Karen Zeidan; Rita Farah; Mirna N Chahine; Roland Asmar; Hassan Hosseini; Pascale Salameh; Atul Pathak
Journal:  Vasc Health Risk Manag       Date:  2016-03-17
View more
  28 in total

1.  The Effect of Laparoscopic Sleeve Gastrectomy on Subclinical Atherosclerosis in Patients with Severe Obesity.

Authors:  Yusuf Cekici; Bedri Caner Kaya; Hasan Elkan
Journal:  Obes Surg       Date:  2020-11-14       Impact factor: 4.129

2.  Association of body mass index with life expectancy with and without cardiovascular disease.

Authors:  Nazanin Fekri; Pegah Khaloo; Azra Ramezankhani; Mohammad Ali Mansournia; Fereidoun Azizi; Farzad Hadaegh
Journal:  Int J Obes (Lond)       Date:  2019-10-07       Impact factor: 5.095

3.  Multi-state analysis of hypertension and mortality: application of semi-Markov model in a longitudinal cohort study.

Authors:  Azra Ramezankhani; Michael J Blaha; Mohammad Hassan Mirbolouk; Fereidoun Azizi; Farzad Hadaegh
Journal:  BMC Cardiovasc Disord       Date:  2020-07-06       Impact factor: 2.298

4.  Blood pressure components and incident cardiovascular disease and mortality events among Iranian adults with chronic kidney disease during over a decade long follow-up: a prospective cohort study.

Authors:  Ashkan Hashemi; Sormeh Nourbakhsh; Samaneh Asgari; Mohammadhassan Mirbolouk; Fereidoun Azizi; Farzad Hadaegh
Journal:  J Transl Med       Date:  2018-08-15       Impact factor: 5.531

5.  National trends of pre-hypertension and hypertension among Iranian adolescents across urban and rural areas (2007-2011).

Authors:  Parisa Amiri; Golnaz Vahedi-Notash; Parisa Naseri; Davood Khalili; Seyed Saeed Hashemi Nazari; Yadollah Mehrabi; Ali Reza Mahdavi Hazaveh; Fereidoun Azizi; Farzad Hadaegh
Journal:  Biol Sex Differ       Date:  2019-03-29       Impact factor: 5.027

6.  Status of Hypertension in Tehran: Potential impact of the ACC/AHA 2017 and JNC7 Guidelines, 2012-2015.

Authors:  Samaneh Asgari; Pegah Khaloo; Davood Khalili; Fereidoun Azizi; Farzad Hadaegh
Journal:  Sci Rep       Date:  2019-04-23       Impact factor: 4.379

7.  The higher serum endocan levels may be a risk factor for the onset of cardiovascular disease: A meta-analysis.

Authors:  Tianming Zhao; Yao Kecheng; Xuelei Zhao; Xuehua Hu; Jing Zhu; Yingnan Wang; Jixiang Ni
Journal:  Medicine (Baltimore)       Date:  2018-12       Impact factor: 1.817

8.  DUSP1 Is a Potential Marker of Chronic Inflammation in Arabs with Cardiovascular Diseases.

Authors:  Abdelkrim Khadir; Sina Kavalakatt; Mohammed Dehbi; Monira Alarouj; Abdullah Bennakhi; Ali Tiss; Naser Elkum
Journal:  Dis Markers       Date:  2018-12-13       Impact factor: 3.434

9.  Inter-relationships between left ventricular mass, geometry and arterial stiffness.

Authors:  Manal M Alem; Abdullah M Alshehri
Journal:  J Int Med Res       Date:  2020-04       Impact factor: 1.671

10.  Estimation of Cardiovascular Disease Risk Factors in the Undefined Participants of Campaign in Isfahan in 2017.

Authors:  Maryam Bemanalizadeh; Ziba Farajzadegan; Parastou Golshiri
Journal:  Int J Prev Med       Date:  2021-05-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.